Hear from Tucuvi’s CEO on what our $20M Series A means for scaling care management
Looking back at our journey is how I make sense of progress. And one thing hasn’t changed: the problem that led us to start Tucuvi is still very much here. Sometimes people call me skeptical. I prefer to think I’m unwilling to accept the status quo and that things can’t be better.
Capacity is still broken. Waiting times keep growing. Nurses are struggling to manage their workload. Some countries are facing severe nursing shortages. Around 40% of nurses intend to leave the workforce, and more than half report feeling burned out.
As a biomedical engineer, I, like many others on our team, was fortunate during our training to spend months shadowing care teams at hospitals. From pediatric psychiatry (by far the hardest for me), to surgery, oncology, or primary care. When you see the reality up close, it’s easy to understand why some professionals want to quit. The gap between what’s asked of them and what’s possible with the resources available keeps widening.
Tucuvi was built to close that gap.
With our recent $20M Series A, we are now taking that vision further, building technology that meets the real demands of healthcare with rigor, responsibility, and trust.
The foundation
We started building Tucuvi with one goal in mind: to help health organizations and care teams deliver high-quality care to all their patients.
We started by leveraging voice AI to take on the high-volume phone calls care teams were already handling every day, from triage and remote patient monitoring, to transitions of care, medication reconciliation, scheduling, refills, surgical preparation, follow-ups.
We built a voice-based AI agent, LOLA, to handle those interactions, so clinicians could focus on the moments that truly require them.
As we grew, we invested early in enterprise-grade foundations, ensuring our solutions are clinically explainable, interoperable, auditable, and safe to deploy at scale.
That commitment led us to become the first AI platform in Europe to receive regulatory approval as a Class IIb Software as a Medical Device.
It also led to Tucuvi being selected as one of only two healthcare companies in Spain’s national regulatory sandbox for high-risk AI, working with the government to define standards for safe AI deployment.
That same approach is why we chose to be part of the CMS Health Tech Ecosystem pledge in the US. It’s a commitment to building technology that is interoperable, transparent, and designed to reduce burden on clinicians while improving patient care.
It’s about holding ourselves accountable to the standards healthcare deserves. Having deployed clinical AI at scale across dozens of healthcare organizations of difference size and flavours, we feel a responsibility to share what works, what doesn’t, and the practices that help teams use these tools safely and effectively.
What started as a belief is running in production. More than 60 organizations, from health systems to payers and life sciences companies, trust Tucuvi to manage patient interactions.
The Evolution
What began as a conversational AI tool with LOLA has naturally evolved into an Agentic AI Care Management platform. Our agents orchestrate the patient journey and ensure clinical continuity at every touchpoint. While Tucuvi Health Manager, our clinical command center, gives care teams visibility and control over what’s happening across their patient population.
Everywhere we go, we hear the same message from clinical teams: capacity is stretched beyond what is humanly possible. Nurses are responsible for hundreds of patients and only manage to connect with a fraction each week. This isn’t a conversation about dashboards or efficiency scores. It’s about giving nurses back the ability to practice the care they trained for.
I am often asked about the resistance to AI in healthcare. Skepticism is not a barrier, it is a safeguard. The clinical act is sacred, being cautious about new technology is a professional responsibility. That’s is why trust is everything.
We build solutions that are traceable and transparent, and that keep care teams in control. That allow them to delegate up to 80% of high-volume workflows and recover time to focus on higher-risk patients. That helps them succeed in value-based care, for example, reducing COPD readmissions by 5.5% through consistent engagement and early intervention.
But even more importantly, we receive this kind of feedback from patients daily:
“I felt truly listened to and understood during every interaction.”
“Communication was excellent. I received reminders, clear instructions, and quick answers to my questions whenever I needed them.”
“It treated me with kindness and respect. I was always addressed by my name and my preferences were taken into account.”
“The process was very easy to follow. From the first call to the last, I knew what to expect and what I needed to do.”
“Thanks to the regular check-ins, my concerns were detected early and handled before they became serious problems.”
“I felt more confident managing my condition because it explained my results and next steps in a way that I could understand.”
“The service helped me stay out of the hospital and remain independent at home. That made a big difference for me and my family.”
“I would definitely recommend this service to other patients. It gave me peace of mind and made me feel cared for between visits.”
And we’re proud of supporting nurses like this:
“The follow-up system gives us real-time visibility into our patients’ status and helps us prioritize who needs attention first.”
“The alerts are clinically meaningful and easy to act on. They save us time compared with manually calling every patient.”
“Patients arrive at consultations better informed and more engaged. We spend less time on basic questions and more on decisions.”
“The onboarding was smooth. Our team quickly learned how to use the platform and integrate it into daily workflows.”
“The reports are clear and concise. They help us track outcomes over time and communicate value to management.”
“This has reduced unplanned visits and calls to the clinic. Our nurses can focus on the most complex cases.”
“Communication with patients between visits has improved significantly. We detect issues earlier and intervene sooner.”
“The tool respects our clinical criteria. We feel in control of the protocols and can adjust them to our population.”
“Support from the team is excellent. They respond quickly to questions and incorporate our feedback into the product.”
“Implementation did not disrupt our routine. It fit with our existing systems and processes with minimal friction.”
“Overall, it has increased our confidence that vulnerable patients are being monitored and not ‘falling through the cracks’.”
We hear versions of this every single day.
Recently, we supported a health system that attributed 46 lives saved to early detection enabled by our agents. In another region of 400,000 people, vaccination coverage increased fourfold.
At the same time, clinical AI has evolved significantly over the last few years, not only technologically, but also in terms of adoption. Patients (all of us) are already turning to LLMs for diagnosis or care advice, often sharing sensitive information they might hesitate to share with a human for fear of judgment. Healthcare systems are adapting, working to provide solutions that are safe, integrated, and clinically validated.
With all this, the real question becomes unavoidable: how do we scale Tucuvi so every healthcare organization, every government, every care team that could benefit from it, actually can? And how do we do it without losing what made it work in the first place?
Scaling with purpose
This Series A is a commitment to the entire healthcare community.
Every day, I’m inspired by the courage and dedication of those working to improve care, and it reinforces why accepting the status quo was never an option for us. We keep building because we believe healthcare can, and should, be better.
To the patients and clinicians who have walked this path with us: you are the heartbeat of Tucuvi, and you give purpose to every decision we make.
To our team, partners and investors: thank you for believing that the harder path, grounded in clinical safety and empathy, is the one that truly transforms healthcare.
Excited for what’s to come.
María González Manso
CEO and Co-founder
